Related Experiment Video
Updated: Aug 5, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
Anna L Burdeynaya1, Olga I Afanasieva2, Marat V Ezhov1
1Laboratory of Lipid Disorders, Department of Atherosclerosis, A.L. Myasnikov Institute of Clinical Cardiology, Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Insights
Lipoprotein(a) (Lp(a)) and low IgM autoantibodies to oxidized Lp(a) (oxLp(a)) significantly increase calcific aortic valve stenosis (CAVS) risk. This finding is crucial for understanding CAVS development, especially in patients with coronary heart disease (CHD).
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Aortic valve stenosis (AVS) is a prevalent valvular heart disease.
- Lipoprotein(a) (Lp(a)) is a known risk factor for coronary heart disease (CHD) and calcific aortic valve stenosis (CAVS).
- The role of Lp(a) autoantibodies in CAVS pathogenesis remains under investigation.
Purpose of the Study:
- To investigate the association between Lp(a), its autoantibodies (autoAbs), and CAVS.
- To explore these associations in patients with and without concomitant CHD.
- To identify independent predictors of CAVS.
Main Methods:
- A study cohort of 250 patients was divided into three groups: CAVS with CHD, CAVS without CHD, and controls.
- Logistic regression analysis was employed to identify predictors of CAVS.
- Levels of Lp(a) and IgM autoantibodies to oxidized Lp(a) (oxLp(a)) were measured.
Main Results:
- Lp(a) levels, IgM autoAbs to oxLp(a), and age were identified as independent predictors of CAVS.
- Elevated Lp(a) (≥30 mg/dL) combined with decreased IgM autoAbs (<9.9 lab. Units) showed a significant association with CAVS (OR 6.4) and CAVS with CHD (OR 17.3).
- IgM autoantibodies to oxLp(a) were associated with CAVS independently of Lp(a) levels and other risk factors.
Conclusions:
- Higher Lp(a) and lower IgM autoantibodies to oxLp(a) levels are strongly associated with an increased risk of CAVS.
- IgM autoantibodies to oxLp(a) play a significant role in CAVS development, irrespective of Lp(a) concentration.
- These findings highlight potential therapeutic targets for managing CAVS.
Abstract:
Aortic valve stenosis is the most common valvular heart disease in the Western world. Lipoprotein(a) (Lp(a)) is an independent risk factor of coronary heart disease (CHD) and calcific aortic valve stenosis (CAVS). The aim of this study was to assess the role of Lp(a) and its autoantibodies [autoAbs] in CAVS in patients with and without CHD. We included 250 patients (mean age 69 ± 3 years, males 42%) and divided them into three groups. There were two groups of patients with CAVS depending on the presence (group 1) or absence of CHD (group 2). The control group included the patients without CHD or CAVS. According to logistic regression analysis, levels of Lp(a), IgM autoAbs to oxidized Lp(a) (oxLp(a)), and age were independent predictors of CAVS. A concomitant increase in Lp(a) level (≥30 mg/dL) and a decrease in IgM autoAbs concentration (<9.9 lab. Units) are associated with CAVS with an odds ratio (OR) of 6.4, p < 0.01, and with CAVS and CHD with an OR of 17.3, p < 0.001. IgM autoantibodies to oxLp(a) are associated with calcific aortic valve stenosis regardless of Lp(a) concentration and other risk factors. Higher Lp(a) and lower IgM autoantibodies to oxLp(a) levels are associated with a much higher risk of calcific aortic valve stenosis.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Atherosclerosis I: Introduction
Rheumatic Heart Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease II: Pathophysiology
Aortic Regurgitation I: Introduction

